EP-1061: Progressive resistive exercise training for shoulder function: a randomised controlled trial  by Murthy, V. et al.
ESTRO 35 2016                                                                                                                                                    S511 
________________________________________________________________________________ 
Conclusion: The larynx preservation protocol achieves the 
same survival rates that total laryngectomy, contributing 50% 
of preservation of organ function. It is necessary more cases 
for a final evaluation.  
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Purpose or Objective: To robustly assess features of 
radiotherapy-induced fibrosis in patients within the 
reconstructive/plastic surgery clinic and establish a baseline 
for comparison against following treatment.  
 
Material and Methods: Patients awaiting fat-graft treatment 
for radiotherapy-induced fibrosis were assessed with regard 
to their symptomatology using a quality of life questionnaire. 
They also underwent clinical examination for functional 
impairment secondary to the fibrotic process and assessment 
of the microcirculation and mechanical properties by speckle 
contrast blood flow assessment and themographic imaging, 
durometry and skin cutometry respectively. The results were 
compared against age-matched healthy controls.  
 
Results: Health-related quality of life in these patients was 
impaired, with 36% of patients overall rating their quality as 
“fair” or “very poor”. On clinical assessment, movement of 
the neck was impaired with approximately 50% reduction in 
flexion and rotation movements. 100% of patients had 
sensory impairment in the fibrotic region. Microcirculatory 
changes were seen with increased flux (mean = 411.47 vs. 
348.83 contralaterally) and temperature (mean difference of 
1.3°C vs. control) in the regions of fibrotic change compared 
with the contralateral side and with controls respectively. 
Significant differences in hardness of skin and subcutaneous 
tissues of the neck were seen between treated and untreated 
areas and between patients and controls (51.5 vs. 16.8 
durometer units). Significant increases in the firmness and 
fatiguability of the skin were seen on cutometry and non-
significant decreases in elasticity.  
 
Conclusion: Our methods provide us with important baseline 
information about how affected our patients are by 
radiotherapy-induced fibrosis. This baseline can be compared 
post-operatively to quantify benefits afforded by fat-graft 
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Purpose or Objective: To assess efficacy & toxicity of 
reduced CTV margins in the IMRT of head and neck cancers 
 
Material and Methods: Between 2010 and 2015, 83 
consecutive patients with locally advanced Head & Neck 
squamous cell cancers, treated with a radical intent with 
chemoradiation by IMRT, with reduced CTV margins were 
analysed for local control, toxicity, compliance & survival. 
Nodal delineation was as per DAHANCA guidelines.Toxicity 
was assessed by CTCAE version 4.0 
 
Results: Median age of the cohort was 58 years (32-76) with 
65 males & 18 female patients. Hypopharyngeal cancers were 
47% followed by oropharyngeal (27%) and laryngeal (26%) 
cancers. TNM stage grouping in the cohort was IVA in 72% 
followed by IVB & III. CECT based delineation of the involved 
primary and nodal volumes were expanded uniformly by 5 
mm to create the high risk CTV and this expanded by 5 mm to 
create the PTV1. Similarly the involved nodal level was 
considered as intermediate risk (PTV2) and remaining nodal 
levels as low risk (PTV3). Inverse planning was performed 
using Varian Eclipse planning system with dose constraints to 
OAR’s as per guidelines. SIB-IMRT was delivered to a dose 70, 
63 and 56Gy in 35 fractions to high, intermediate and low risk 
volumes respectively. Median overall treatment time was 
49(40-70) days. 24% of the patients received 6 fractions per 
week. Weekly Cisplatin (40mg/sqm) was given concurrently 
with IMRT except in 10 patients receiving Carboplatin (2AUC), 
90% received a minimum of 4 cycles. Grade 3 mucositis was 
seen in 40%, grade 3 dysphagia in 6%, radiation dermatitis 
was predominantly grade 2, Xerostomia was predominantly 
grade 1 in 93%, 10% required placement of nasogastric tube 
and treatment interruption. Myelosuppression of grade 3 was 
seen towards completion of treatment in 24% of the cohort, 
predominantly in total leukocyte count. A complete response 
of 90% and 86% was seen in primary and nodal disease at the 
end of the treatment and eventually in 100% and 94% in first 
three months. 3 patients needed neck dissection and showed 
residual disease. At a median follow up of 2 years, 62 
patients are controlled with an overall survival of 74.7%. 
Deaths are due to distant metastasis in 4% and 8% due to 
other medical causes.  
 
Conclusion: Reduction of CTV margin to 5 mm seems to be 
appropriate, with good loco-regional control, reduced overall 
treatment time, better compliance, reduced toxicity & 
superior outcomes. This study forms basis for a prospective 
controlled randomised study to generate further evidence. 
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Purpose or Objective: Significant shoulder dysfunction 
persists in a majority of the oral cancer patients after surgery 
even on performing active exercises. Progressive Resistive 
Exercise Training (PRET) involves gradual and incremental 
increase in resistance for improved muscular rehabilitation. 
This randomized controlled trial was done to compare active 
shoulder exercise and PRET with active exercises for shoulder 
dysfunction in patients undergoing Radiation Therapy (RT).  
 
Material and Methods: Ninety four eligible patients with 
shoulder abduction Active Range of Motion (AROM) ≤ 90° 
were randomized to either active shoulder exercises only ( 
n=47) or PRET plus active shoulder exercises (n=47). 
Resistance was gradually progressed over 6 weeks according 
to the capacity of patients in PRET arm. AROM was measured 
at week 0, 2, 4, 6 and 6 months. Shoulder Pain and Disability 
Index (SPADI) was also measured in both arms at the base 
line and after completion of the intervention at the end of 
6th week.  
 
Results: Results: Improvement in shoulder abduction AROM 
was significantly greater in the PRET Arm (mean = 73.3° ± 
14.3° at baseline to 132.5° ± 28.5° at 6 weeks) than in 
standard arm (mean = 74.8° ± 12.5° at baseline to 97.1° ± 
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22.4° at 6weeks, p<0.001). The SPADI pain and disability 
score also indicated significant improvement in PRET arm at 
6 weeks when compared to standard arm (p < 0.05)  
 
Conclusion: Early institution of PRET program provides 
maximal benefit to the post surgical oral cancer patients 
undergoing RT than active exercises only and should be 
considered the standard of care. 
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Purpose or Objective: To evaluate the efficacy of primary 
(chemo)radiation therapy in a organ-sparing combined or 
radical nonsurgical treatment modality for tongue squamous 
cell carcinoma. 
 
Material and Methods: From January 2003 to January 2015 
166 consecutive patients with histologically proven the base 
(49 pts, 30%) and the mobile part of the tongue (MOT) cancer 
(117 pts, 70%) received radiotherapy +/- chemotherapy 
(concomitant) to the dose of 50Gy in the preoperative mode 
treatment and to 70Gy as radical irradiation. Most of them 
suffered from III (39%) and IV (35%) staged tumors, with the 
invasive nature of growth at 88 % and regional metastases in 
70%. Patients with base of tongue (BOT) cancer had locally 
advanced process more often (92% vs 66%), especially stage 
IV (69% vs 20%). Nonresectable process was diagnosed in 38% 
patients with BOT cancer and in 23% cases of MOT cancer 
primary tumor. We also assessed tumors for potential biologic 
predictors of treatment effectiveness (p53, COX-2 , VEGF, 
Ki67, E-cadherin , p21 , Bcl- 2 and others). Radiomodification 
with 5FU/cisplatin or cisplatin/cetuximab was performed in 
133 (80%) cases. All patients started with photon external 
beam radiation to the dose of 50Gy with subsequent decision 
of necessity of surgery by applying our prognostic model 
(combined clinical and biological predictive model with 
multivariate analysis, p<0,05). Nonsurgical treatment was 
performed in 56 (34%) cases. Patients with BOT primary 
tumor underwent conservative therapy more often (62% vs 
22%). Combined treatment with surgery was performed to 
110 (66%) patients, with the preservation of the organ in 76 
(69%) cases. Organ-sparing surgery was possible in 89 (76%) 
cases of MOT cancer and only in 16 (33%) cases of BOT 
cancer. 
 
Results: After irradiation we observed complete response in 
21% cases of BOT cancer and 7% of MOT cancer, partial 
response in 79% and 82% respectively. Stabilization and 
progression was diagnosed in 8% and 3% of cases MOT cancer. 
Complete morphological response in surgically removed 
tissues was obtained in 48% of BOT cancers and 22% of MOT 
cancers. 5-year general and disease-free survival were 70% 
and 58% respectively and there was not reliable difference 
between localizations. Surgical treatment for local relapse 
were performed 30 of 62 (48%) patients. 
 
Conclusion: In our single experience primary 
(chemo)radiation therapy has been shown to be feasible and 
resulted in high probability of organ-sparing treatment with 
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Purpose or Objective: Disease free survival and overall 
survival figures for early laryngeal cancer (T1) are excellent 
regardless of treatment modality used; either laser surgery or 
external beam radiotherapy. Randomised controlled trials of 
laser versus radiotherapy have failed to recruit. In comparing 
treatment modalities we must therefore look for other 
comparators including cost efficacy and patient reported 
outcomes (PROMS) . Voice outcomes are an important PROM 
in larynx cancer treatment. 
 
Material and Methods: A retrospective review of all patients 
treated at a regional Head and Neck centre over a 7 year 
period with T1a and T1b laryngeal cancers and subsequently 
followed up in the voice clinic. Patients were routinely asked 
to complete the Voice Handicap Index 10 (VHI-10) as part of 
standard care. The VHI-10 is an abbreviated version of the 
VHI which gives a subjective score of the degree of handicap 
experienced by the patient due to voice quality (Rosen 2004). 
The abbreviated score is validated and consistent. High 
scores indicate greater disability due to voice effects. VHI-10 
scores and data on disease status were collected. Patients 
were treated with either Type 1,2 or 3 carbon dioxide laser 
cordotomy (as per ELS classification) by a single surgeon or 
external beam radiotherapy to 55Gy in 20 fractions in 26 days 
with 6MV photons to a CT planned volume to the larynx only 
(no elective nodal irradiation)(PTV = CTV+5mm). Patients 
treated with radiotherapy usually had contraindications to 
laser surgery (tumour position or access). 
 
Results: 44 patients were identified with follow-up VHI data, 
30 of these had been treated with laser surgery (28 with T1a) 
and 14 with radiotherapy (8 with T1a). Mean follow up was 
3.01 years (0.5-5 years). Recurrence occurred in two patients 
after laser. One patient underwent further laser excision and 
the other received radiotherapy. There was 100% disease 
specific survival. The results were analysed by a General 
Linear Regression model with multiple imputations to address 
response gaps, using an SBS analysis tool. Both groups showed 
a statistically significant increase in mean VHI-10 scores over 
time and from pre-treatment baselines. VHI scores were 
higher for the radiotherapy treated cohort in the first year of 
follow up. Return to a VHI score of less than 10 was 6-9 
months for laser and 9-12 months for radiotherapy. 
Graph shows average VHI score from pre-treatment up to 62 




Conclusion: PROMs are an appropriate way to compare 
treatment modalities with similar disease outcomes. The VHI-
10 is an appropriate PROM for patients treated for laryngeal 
cancer. In an unselected retrospective population subjective 
voice outcomes are no worse with laser than with 
radiotherapy and therefore laser may be a preferred option 
due to lower cost and greater convenience. 
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Purpose or Objective: The treatment of choice for 
recurrences or second tumors of head and neck area, in areas 
